- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
13
Mid-Large Cap Stocks
13 companies
Roche Holding
Market Cap: CHF 283.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 355.10
7D
6.3%
1Y
37.0%
Novartis
Market Cap: CHF 241.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 126.90
7D
1.5%
1Y
36.7%
Tecan Group
Market Cap: CHF 2.3b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 182.20
7D
1.2%
1Y
10.0%
Bachem Holding
Market Cap: CHF 5.6b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 75.05
7D
5.5%
1Y
0.8%
Sandoz Group
Market Cap: CHF 27.5b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 63.62
7D
-3.2%
1Y
35.1%
Cosmo
Market Cap: CHF 1.0b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 63.60
7D
0.3%
1Y
1.3%
SKAN Group
Market Cap: CHF 1.3b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 57.20
7D
1.6%
1Y
-24.3%
Galderma Group
Market Cap: CHF 40.7b
Operates as a dermatology company worldwide.
GALD
CHF 173.65
7D
0.7%
1Y
29.1%
Dottikon ES Holding
Market Cap: CHF 3.7b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 266.50
7D
0%
1Y
-17.5%
Lonza Group
Market Cap: CHF 38.3b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 548.00
7D
-3.5%
1Y
-3.4%
Idorsia
Market Cap: CHF 1.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 6.17
7D
4.5%
1Y
113.7%
Siegfried Holding
Market Cap: CHF 3.1b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 70.70
7D
-4.1%
1Y
-26.0%
PolyPeptide Group
Market Cap: CHF 1.4b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 43.75
7D
4.8%
1Y
76.8%